155 related articles for article (PubMed ID: 10928048)
1. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas.
Wu H; Lotan R; Menter D; Lippman SM; Xu XC
Anticancer Res; 2000; 20(3A):1385-90. PubMed ID: 10928048
[TBL] [Abstract][Full Text] [Related]
2. Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck.
Eriksen JG; Steiniche T; Søgaard H; Overgaard J
APMIS; 2004 Sep; 112(9):560-8. PubMed ID: 15601304
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.
Schipper JH; Frixen UH; Behrens J; Unger A; Jahnke K; Birchmeier W
Cancer Res; 1991 Dec; 51(23 Pt 1):6328-37. PubMed ID: 1933895
[TBL] [Abstract][Full Text] [Related]
4. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
6. Distinct P-cadherin expression in cultured normal human keratinocytes and squamous cell carcinoma cell lines.
Wakita H; Shirahama S; Furukawa F
Microsc Res Tech; 1998 Nov; 43(3):218-23. PubMed ID: 9840799
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
8. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.
Vessey CJ; Wilding J; Folarin N; Hirano S; Takeichi M; Soutter P; Stamp GW; Pignatelli M
J Pathol; 1995 Jun; 176(2):151-9. PubMed ID: 7636625
[TBL] [Abstract][Full Text] [Related]
9. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin: a differentiation marker in thyroid malignancies.
Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
[TBL] [Abstract][Full Text] [Related]
11. Correlation of E-cadherin and alpha-catenin expression with differentiation of oral squamous cell carcinoma.
Sakaki T; Wato M; Tamura I; Nakajima M; Morita S; Kakudo K; Shirasu R; Tanaka A; Sakaki T
J Osaka Dent Univ; 1999 Oct; 33(2):75-81. PubMed ID: 10863478
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin expression as a differentiation marker in gastric cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of E-cadherin in human head and neck cancer.
Sorscher SM; Russack V; Cagle M; Feramisco JR; Green MR
Arch Pathol Lab Med; 1995 Jan; 119(1):82-4. PubMed ID: 7802560
[TBL] [Abstract][Full Text] [Related]
15. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study on the expression of E-cadherin in normal tissues and squamous cell carcinomas of the uterine cervix].
Honda S
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):517-23. PubMed ID: 1619310
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.
Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Julián-González R; Galindo-Villardón P; Cruz-Hernández JJ; Bullón-Sopelana A
Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E100-5. PubMed ID: 16505783
[TBL] [Abstract][Full Text] [Related]
18. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture.
Gasparoni A; Fonzi L; Schneider GB; Wertz PW; Johnson GK; Squier CA
Arch Oral Biol; 2004 Aug; 49(8):653-64. PubMed ID: 15196983
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines.
Nakagawa T; Murakami A; Torii M; Nawata S; Takeda O; Sugino N
Oncol Rep; 2007 Jul; 18(1):175-9. PubMed ID: 17549365
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
